Drugs / Lu AE04621
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02649608 | Jan → Dec 2016 | Parkinson disease | H. Lundbeck A/S | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lu AE04621 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02649608 ↗ |
| Route | Oral | “After Ascending Oral Doses of Lu AE04621” NCT02649608 ↗ |